Stock Rating Downgrade
The Value Trend Rating for Lipocine Inc (NASDAQ: LPCN) weakened of late from B to C reflecting eroding fundamentals and low Appreciation Potential. Details supporting this lower rating are included in our next report.
Recent Price Action
Lipocine Inc (NASDAQ: LPCN) stock closed at $9.49 on 6/14/24 after a major increase of 16.0%. Moreover, this advance was accompanied by unusually high trading volume at 194% of normal. The stock has been exceptionally strong relative to the market over the last nine months and has risen 34.0% during the last week.
Current PriceTarget Research Rating
LPCN’s future returns on capital are forecasted to fall short of the cost of capital. Accordingly, the company is expected to continue to be a modest Value Eraser.
Lipocine has a current Value Trend Rating of C (High Neutral). The Value Trend Rating reflects very contradictory signals from PTR’s two proprietary measures of a stock’s attractiveness. Lipocine has a poor Appreciation Score of 20 but a very high Power Rating of 95, and the High Neutral Value Trend Rating results.
Be the first to comment